Sign in Register

Indication

Myocardial infarction prevention

Myocardial infarction prevention refers to clinical strategies aimed at averting acute myocardial necrosis caused by prolonged, severe ischemia within the cardiovascular system. Read more about Myocardial infarction prevention

484 drugs 188 manufacturers

Advertisement

Drugs that treat it

Common Myocardial infarction prevention therapies.

Showing 388–396 of 484 drugs

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
BLU PHARMACEUTI

ROSUVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
BLU PHARMACEUTI

SIMVASTATIN

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+13
BLU PHARMACEUTI

PRAVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
MYLAN INSTITUTI

SIMVASTATIN

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+13
MYLAN INSTITUTI

ASPIRIN EC (aspirin)

NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·MYOCARDIAL REINFARCTION PREVENTION·+11
PD-RX PHARM

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
PD-RX PHARM

LOVASTATIN

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+7
PD-RX PHARM
Filter & compare in the drug finder →Opens the drug finder with Myocardial infarction prevention preselected.

News & literature

Coming soon

Related codes

Coming soon

Related conditions & guidelines

Coming soon

About Myocardial infarction prevention.

Myocardial infarction prevention refers to clinical strategies aimed at averting acute myocardial necrosis caused by prolonged, severe ischemia within the cardiovascular system.

This indication encompasses primary prevention in individuals with elevated cardiovascular risk factors—such as diabetes, dyslipidemia, or hypertension—and secondary prevention in patients with established coronary artery disease, prior acute coronary syndromes, or revascularization.

Pathophysiologically, it focuses on stabilizing vulnerable coronary atherosclerotic plaques, mitigating endothelial inflammation, suppressing platelet aggregation, and maintaining an adequate balance between myocardial oxygen supply and demand to deter acute thrombotic occlusion.

Personalize your experience

Follow Myocardial infarction prevention and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it